Market Place
Sourcing Support
Roche Purchases Shares In Tender Offer For 89Bio
30 Oct 2025 //
GLOBENEWSWIRE
Roche Pens $1B Deal For Respiratory Bispecific From China
30 Oct 2025 //
FIERCE BIOTECH
Roche Gets CE Mark for Elecsys Dengue Ag High-Throughput Test
29 Oct 2025 //
GLOBENEWSWIRE
Roche`s Flatiron Health Debuts 6 New Blood Cancer Data Sets
29 Oct 2025 //
FIERCE BIOTECH
Roche`s Gazyva/Gazyvaro Shows Positive Phase III Results
28 Oct 2025 //
GLOBENEWSWIRE
Roche Pads Case For Gazyva In Immune-Mediated Kidney Conditions
28 Oct 2025 //
FIERCE PHARMA
Roche Axes 4 Chugai Solid Tumor Assets In Early-Phase Clear-Out
24 Oct 2025 //
FIERCE BIOTECH
Roche Sustains 7% Sales Growth, Boosts Full-Year Earnings Outlook
23 Oct 2025 //
GLOBENEWSWIRE
Changes To The Roche Enlarged Corporate Executive Committee
23 Oct 2025 //
GLOBENEWSWIRE
Roche Overcomes Drug-Specific Struggles, Currency Woes In Q3
23 Oct 2025 //
FIERCE PHARMA
Roche Raises Profit View, but Weak Dollar Weighs on Sales
23 Oct 2025 //
REUTERS
Roche Unveils Positive Ph 3 Results For Vamikibart In UME Edema
22 Oct 2025 //
INDPHARMAPOST
Roche’s Gazyva Expands Out of Cancer With FDA Approval for Lupus
22 Oct 2025 //
BIOSPACE
Exelixis Kinase Blocker Sets Survival Bar In Colorectal Cancer
21 Oct 2025 //
PRESS RELEASE
Ventus Pharma Collaborates With Genentech On Small-Molecule
21 Oct 2025 //
BUSINESSWIRE
ESMO: The ADC `Rollercoaster` Rides On With Next-Gen Meds
21 Oct 2025 //
FIERCE BIOTECH
Genentech`s Tecentriq Demonstrates Major Survival Gains
20 Oct 2025 //
PHARMIWEB
EMPRESS Study Shows Giredestrant Cut Tumor Growth in Early Cancer
20 Oct 2025 //
PR NEWSWIRE
Roche Heads To FDA As Eye Disease Trials Yield Mixed Data
20 Oct 2025 //
FIERCE BIOTECH
Hansoh Pharma Inks $1.45B Colorectal Cancer Drug Deal With Roche
20 Oct 2025 //
REUTERS
ESMO: Merck Lays Out Keytruda`s Landmark Win In Ovarian Cancer
18 Oct 2025 //
FIERCE PHARMA
ESMO: Roche Wants Oral SERD To Benefit `All Comers`
18 Oct 2025 //
FIERCE BIOTECH
ESMO: Enhertu Wields 2-Fisted Power In Early Breast Cancer
18 Oct 2025 //
FIERCE PHARMA
Genentech Presents Ph3 Data for Vamikibart in UME
17 Oct 2025 //
PHARMIWEB
CHMP Backs Roche`s Gazyva For Lupus Nephritis In EU
17 Oct 2025 //
GLOBENEWSWIRE
Roche`s Appeal Denied By Supreme Court In Risdiplam Generic Drug
17 Oct 2025 //
BUSINESS STD
Hansoh, Chugai Ink Separate And Lucrative Licensing Agreements
17 Oct 2025 //
FIERCE BIOTECH
Roche Unveils Sequencing Breakthrough, Wins Guinness Record
16 Oct 2025 //
GLOBENEWSWIRE
Genentech`s 1St DTC Program Centers On Discounted Xofluza
16 Oct 2025 //
FIERCE PHARMA
Roche Challenges Natco`s Generic Risdiplam Launch In India
14 Oct 2025 //
ECONOMICTIMES
Roche Showcases Science And Cancer Care Advances At ESMO 2025
13 Oct 2025 //
GLOBENEWSWIRE
Roche, Lilly`s Blood Test for Alzheimer`s diagnosis gets approval
13 Oct 2025 //
REUTERS
Natco Wins Patent Battle To Launch Generic `Risdiplam`
11 Oct 2025 //
ECONOMICTIMES
Roche Launches Ai Kidney Klinrisk Algorithm Panel For (CKD)
06 Oct 2025 //
GLOBENEWSWIRE
Genentech Awarded $124M In Cabilly Patent Dispute With Biogen
06 Oct 2025 //
FIERCE PHARMA
Change In The Roche Board Of Directors
03 Oct 2025 //
GLOBENEWSWIRE
FDA Approves Roche’s Tecentriq with Lurbinectedin for ES-SCLC
03 Oct 2025 //
PRESS RELEASE
How Akero’s MASH Success Drove Roche’s $3.5B Takeout of 89bio
03 Oct 2025 //
BIOSPACE
Jazz Pharma, Roche`s Combo Therapy for Lung Cancer Gets Approval
03 Oct 2025 //
REUTERS
Roche Unveils Next-Gen Troponin T Test For Precise Heart Attack
30 Sep 2025 //
GLOBENEWSWIRE
Labcorp Partners With Roche To Integrate Digital Slide Scanning
30 Sep 2025 //
PRESS RELEASE
Roche Prsent Ocrevus And Fenebrutinib Data at ECTRIMS 2025
24 Sep 2025 //
GLOBENEWSWIRE
Roche Reports Phase 3 Breast Cancer Victory for Oral Serd
24 Sep 2025 //
FIERCE BIOTECH
Zealand Pharma May Sell Future Obesity Drug Direct to Patients
23 Sep 2025 //
REUTERS
Sobi Tops Roche in Rare Disease Patients` Reputation Rankings
23 Sep 2025 //
FIERCE PHARMA
Roche`s Obesity Ambition Not Reliant on One Megablockbuster
23 Sep 2025 //
FIERCE BIOTECH
Roche Unveils Strategy to Become `Top 3` Obesity Company
22 Sep 2025 //
FIERCE BIOTECH
Next Steps for Roche`s High-Cost Obesity Pipeline
19 Sep 2025 //
FIERCE BIOTECH
Roche Gets CE Mark for Accu-Chek SmartGuide CGM
19 Sep 2025 //
INDPHARMAPOST
CHMP Backs EU Approval of Roche`s Lunsumio for Lymphoma
19 Sep 2025 //
GLOBENEWSWIRE
Roche Gets CLIA Moderate Complexity For Ionify Vitamin D Test
18 Sep 2025 //
PR NEWSWIRE
Roche Becomes MASH Player via $3.5 B Deal for 89bio, Ph. 3 Drug
18 Sep 2025 //
GLOBENEWSWIRE
Roche Pharma, 10 Govt Hospitals Partner to Boost India Trials
14 Sep 2025 //
ECONOMICTIMES
BioNTech, DualityBio Ph 3 ADC Meets Goal in HER2+ Breast Cancer
06 Sep 2025 //
PRESS RELEASE
Roche`s Vabysmo Data Reinforce Efficacy, Safety in nAMD
05 Sep 2025 //
GLOBENEWSWIRE
Roche Gets CE Mark for Contivue with Susvimo for nAMD
04 Sep 2025 //
GLOBENEWSWIRE
Roche Pharma India Announces 2nd LEAP Scholarship Program Winners
03 Sep 2025 //
EXPRESSPHARMA
Roche Makes Preclinical IBD Play in $420M+ OMass Pact
03 Sep 2025 //
BIOSPACE
Roche, Alnylam to Initiate Phase 3 Trial of Zilebesiran
31 Aug 2025 //
PRESS RELEASE
Foresight Diagnostics Licenses PhasED-Seq™ to Roche
30 Aug 2025 //
PR NEWSWIRE
